• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厘清帕金森病中路易小体与黑质神经元丢失之间的关系。

Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.

机构信息

Queen Square Brain Bank for Neurological Disorders, London, UK.

出版信息

J Parkinsons Dis. 2011;1(3):277-86. doi: 10.3233/JPD-2011-11046.

DOI:10.3233/JPD-2011-11046
PMID:23939308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4196643/
Abstract

Progressive rostral spread of Lewy body (LB) pathology is thought to reflect the clinical course of Parkinson's disease (PD) although several studies have suggested that LBs are not the toxic species responsible for cell death. We investigated the relationship between nigral dopaminergic cell loss, distribution and density of α-synuclein-immunoreactive LBs and duration of motor symptoms in 97 patients with PD. Density of pigmented neurons was measured in a single section of one half of the substantia nigra (SN) with delineation of the dorsal and ventral tiers whereas the cortical and nigral LB densities were determined using a morphometric approach. The density of nigral neurons was estimated to decrease by 2% each year after confirmation of the clinical diagnosis of PD but showed marked heterogeneity with some PD patients with longer duration of illness still possessing a significant number of preserved pigmented nigral neurons at the time of death. An average 15% of surviving nigral neurones contained LBs and the age-adjusted proportion of LB-bearing neurons appeared relatively stable throughout the disease duration. No difference was observed in the age at death or duration of disease with respect to Braak PD stages. The nigral neuronal density was unrelated to either the Braak PD stage or to cortical LB densities. We conclude that nigral neuronal loss is slow and shows considerable variation in PD. Our data also provides no support for a primary pathogenic role of LBs as neither their distribution nor density was associated with the severity of nigral cell loss.

摘要

路易小体(LB)病理的进行性向喙侧扩散被认为反映了帕金森病(PD)的临床病程,尽管一些研究表明路易小体并非导致细胞死亡的毒性物质。我们调查了97例PD患者中黑质多巴胺能细胞丢失、α-突触核蛋白免疫反应性路易小体的分布和密度与运动症状持续时间之间的关系。在黑质(SN)一半的单个切片中测量色素神经元的密度,并划分背侧和腹侧层,而皮质和黑质路易小体密度则采用形态计量学方法确定。在确诊PD临床诊断后,估计黑质神经元密度每年下降2%,但显示出明显的异质性,一些病程较长的PD患者在死亡时仍有大量保存的色素性黑质神经元。平均15%存活的黑质神经元含有路易小体,且在整个疾病过程中,经年龄调整的含路易小体神经元比例相对稳定。在死亡年龄或疾病持续时间方面,未观察到与Braak PD分期相关的差异。黑质神经元密度与Braak PD分期或皮质路易小体密度均无关。我们得出结论,黑质神经元丢失缓慢,在PD中表现出相当大的变异性。我们的数据也不支持路易小体的主要致病作用,因为它们的分布和密度均与黑质细胞丢失的严重程度无关。

相似文献

1
Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.厘清帕金森病中路易小体与黑质神经元丢失之间的关系。
J Parkinsons Dis. 2011;1(3):277-86. doi: 10.3233/JPD-2011-11046.
2
Does levodopa accelerate the pathologic process in Parkinson disease brain?左旋多巴会加速帕金森病大脑的病理进程吗?
Neurology. 2011 Oct 11;77(15):1420-6. doi: 10.1212/WNL.0b013e318232ab4c. Epub 2011 Sep 14.
3
Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.散发性路易体病和帕金森病中黑质神经元丢失的分期依赖性
Mov Disord. 2014 Sep;29(10):1244-51. doi: 10.1002/mds.25952. Epub 2014 Jul 3.
4
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
5
Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.α-突触核蛋白在黑质细胞内累积过程中线粒体复合物 IV 的可变表达。
Parkinsonism Relat Disord. 2021 Sep;90:57-61. doi: 10.1016/j.parkreldis.2021.08.001. Epub 2021 Aug 6.
6
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.CD8 T 细胞在帕金森病早期就已经浸润黑质,且早于突触核蛋白病出现。
Brain. 2020 Dec 1;143(12):3717-3733. doi: 10.1093/brain/awaa269.
7
Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.黑质中路易小体和路易神经突内囊泡单胺转运体2呈阳性免疫反应性。
Neurosci Lett. 2006 Apr 3;396(3):187-91. doi: 10.1016/j.neulet.2005.11.068. Epub 2005 Dec 28.
8
[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].[帕金森病中的路易小体形成:神经退行性变还是神经保护?]
Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. doi: 10.5692/clinicalneurol.48.981.
9
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.帕金森病脑中的路易体提取物在小鼠和猴子中引发α-突触核蛋白病理和神经退行性变。
Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18.
10
Nigral pathology and parkinsonian signs in elders without Parkinson disease.老年人群中无帕金森病患者的黑质病理与帕金森病体征。
Ann Neurol. 2012 Feb;71(2):258-66. doi: 10.1002/ana.22588.

引用本文的文献

1
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson's disease.帕金森病早期阶段,pSer129 α-突触核蛋白的突触富集与多巴胺能神经支配缺失相关。
Nat Commun. 2025 Jul 18;16(1):6630. doi: 10.1038/s41467-025-61052-1.
2
Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology.路易体痴呆的当前管理策略及基于疾病病理生理学的未来方向。
Mol Neurodegener. 2025 Jul 1;20(1):78. doi: 10.1186/s13024-025-00856-7.
3
Physics of Protein Aggregation in Normal and Accelerated Brain Aging.正常与加速脑老化过程中蛋白质聚集的物理学
Bioessays. 2025 Aug;47(8):e70030. doi: 10.1002/bies.70030. Epub 2025 Jun 20.
4
A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap.一种解释阿尔茨海默病、帕金森病和路易体痴呆症重叠现象的假说。
Alzheimers Dement. 2025 Jun;21(6):e70363. doi: 10.1002/alz.70363.
5
Dementia with Lewy bodies and Parkinson disease dementia - the same or different and is it important?路易体痴呆和帕金森病痴呆——相同还是不同,这重要吗?
Nat Rev Neurol. 2025 May 12. doi: 10.1038/s41582-025-01090-x.
6
Electrophysiological characterisation of intranigral-grafted hiPSC-derived dopaminergic neurons in a mouse model of Parkinson's disease.帕金森病小鼠模型中脑黑质内移植的人诱导多能干细胞衍生多巴胺能神经元的电生理特征
Stem Cell Res Ther. 2025 May 9;16(1):232. doi: 10.1186/s13287-025-04344-z.
7
Criterion for Assessing Accumulated Neurotoxicity of Alpha-Synuclein Oligomers in Parkinson's Disease.评估帕金森病中α-突触核蛋白寡聚体累积神经毒性的标准。
Int J Numer Method Biomed Eng. 2025 Apr;41(4):e70027. doi: 10.1002/cnm.70027.
8
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
9
MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.MJF-14邻近连接分析可检测早期非包涵体α-突触核蛋白病变,具有更高的特异性和敏感性。
NPJ Parkinsons Dis. 2024 Nov 29;10(1):227. doi: 10.1038/s41531-024-00841-9.
10
Current insights and assumptions on α-synuclein in Lewy body disease.目前对路易体病中α-突触核蛋白的认识和假设。
Acta Neuropathol. 2024 Aug 14;148(1):18. doi: 10.1007/s00401-024-02781-3.

本文引用的文献

1
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?路易体和阿尔茨海默病病理学在帕金森病痴呆中的作用:哪个更重要?
Brain. 2011 May;134(Pt 5):1493-1505. doi: 10.1093/brain/awr031.
2
From tau phosphorylation to tau aggregation: what about neuronal death?从 tau 磷酸化到 tau 聚集:神经元死亡呢?
Biochem Soc Trans. 2010 Aug;38(4):967-72. doi: 10.1042/BST0380967.
3
The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.路易体痴呆、帕金森病和帕金森病痴呆中α-突触核蛋白聚集的突触病理学。
Acta Neuropathol. 2010 Aug;120(2):131-43. doi: 10.1007/s00401-010-0711-0. Epub 2010 Jun 20.
4
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.年龄与帕金森病晚期进展的关系:临床病理研究。
Brain. 2010 Jun;133(Pt 6):1755-62. doi: 10.1093/brain/awq059. Epub 2010 Apr 5.
5
Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.蛋白水解酶抗性的α-突触核蛋白在人类路易体病和 A53Tα-突触核蛋白转基因小鼠的突触前体中沉积。
Acta Neuropathol. 2010 Aug;120(2):145-54. doi: 10.1007/s00401-010-0676-z. Epub 2010 Mar 26.
6
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.帕金森病的神经病理学评估:完善诊断标准。
Lancet Neurol. 2009 Dec;8(12):1150-7. doi: 10.1016/S1474-4422(09)70238-8.
7
A clinico-pathological study of subtypes in Parkinson's disease.帕金森病亚型的临床病理研究。
Brain. 2009 Nov;132(Pt 11):2947-57. doi: 10.1093/brain/awp234. Epub 2009 Sep 16.
8
Lewy body pathology in normal elderly subjects.正常老年受试者中的路易体病理改变。
J Neuropathol Exp Neurol. 2009 Jul;68(7):816-22. doi: 10.1097/NEN.0b013e3181ac10a7.
9
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.路易体障碍的统一分期系统:与黑质纹状体变性、认知障碍及运动功能障碍的相关性
Acta Neuropathol. 2009 Jun;117(6):613-34. doi: 10.1007/s00401-009-0538-8. Epub 2009 Apr 28.
10
Research in motion: the enigma of Parkinson's disease pathology spread.动态研究:帕金森病病理传播之谜
Nat Rev Neurosci. 2008 Oct;9(10):741-5. doi: 10.1038/nrn2477. Epub 2008 Sep 4.